Cargando…

A Western‐style dietary pattern is associated with cerebrospinal fluid biomarker levels for preclinical Alzheimer's disease—A population‐based cross‐sectional study among 70‐year‐olds

BACKGROUND: Diet may be a modifiable factor for reducing the risk of Alzheimer's disease (AD). Western‐style dietary patterns are considered to increase the risk, whereas Mediterranean‐style dietary patterns are considered to reduce the risk. An association between diet and AD‐related biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samuelsson, Jessica, Kern, Silke, Zetterberg, Henrik, Blennow, Kaj, Rothenberg, Elisabet, Wallengren, Ola, Skoog, Ingmar, Zettergren, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129853/ https://www.ncbi.nlm.nih.gov/pubmed/34027029 http://dx.doi.org/10.1002/trc2.12183

Ejemplares similares

Interactions between dietary patterns and genetic factors in relation to incident dementia among 70-year-olds
por: Samuelsson, Jessica, et al.
Publicado: (2021)

Reproductive period and preclinical cerebrospinal fluid markers for Alzheimer disease: a 25-year study
por: Najar, Jenna, et al.
Publicado: (2021)

A Non-APOE Polygenic Risk Score for Alzheimer’s Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds
por: Skoog, Ingmar, et al.
Publicado: (2021)

Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study
por: Rådestig, Maya Arvidsson, et al.
Publicado: (2023)

Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample
por: Arvidsson Rådestig, Maya, et al.
Publicado: (2023)

Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein
por: Zettergren, Anna, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers, Brain Structural and Cognitive Performances Between Normotensive and Hypertensive Controlled, Uncontrolled and Untreated 70-Year-Old Adults
por: Badji, Atef, et al.
Publicado: (2022)

Prevalence of preclinical Alzheimer disease: Comparison of current classification systems
por: Kern, Silke, et al.
Publicado: (2018)

Association between serum urate and CSF markers of Alzheimer's disease pathology in a population‐based sample of 70‐year‐olds
por: Fatima, Tahzeeb, et al.
Publicado: (2021)

Time trends in nutrient intake and dietary patterns among five birth cohorts of 70-year-olds examined 1971–2016: results from the Gothenburg H70 birth cohort studies, Sweden
por: Samuelsson, Jessica, et al.
Publicado: (2019)

Low Cerebrospinal Fluid Aβ(42) and Aβ(40) are Related to White Matter Lesions in Cognitively Normal Elderly
por: Skoog, Ingmar, et al.
Publicado: (2018)

Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds
por: Remnestål, Julia, et al.
Publicado: (2021)

Genetic Variation in FOXO3 is Associated with Self-Rated Health in a Population-Based Sample of Older Individuals
por: Zettergren, Anna, et al.
Publicado: (2018)

Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community‐based sample of 70‐year‐olds
por: Dittrich, Anna, et al.
Publicado: (2022)

Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration: The H70 Birth Cohort Study in Gothenburg
por: Dittrich, Anna, et al.
Publicado: (2023)

Reply to “Pathway for ascertaining the role of uric acid in neurodegenerative diseases,” Roman Youssef
por: Dehlin, Mats, et al.
Publicado: (2022)

Slowing gait speed precedes cognitive decline by several years
por: Skillbäck, Tobias, et al.
Publicado: (2022)

Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid
por: Meda, Francisco J., et al.
Publicado: (2023)

Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
por: Höglund, K, et al.
Publicado: (2017)

Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
por: Höglund, K., et al.
Publicado: (2018)

The Gothenburg H70 Birth cohort study 2014–16: design, methods and study population
por: Rydberg Sterner, Therese, et al.
Publicado: (2018)

Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study
por: Stomrud, Erik, et al.
Publicado: (2015)

Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus
por: Jeppsson, A., et al.
Publicado: (2023)

Association between APOE Genotype and Change in Physical Function in a Population-Based Swedish Cohort of Older Individuals Followed Over Four Years
por: Skoog, Ingmar, et al.
Publicado: (2016)

Socioeconomic status, gender and dementia: The influence of work environment exposures and their interactions with APOE ɛ4
por: Hasselgren, Caroline, et al.
Publicado: (2018)

Passive and active suicidal ideation in a population-based sample of older adults: Associations with polygenic risk scores of relevance for suicidal behavior
por: Zettergren, Anna, et al.
Publicado: (2023)

Cerebrospinal Fluid Analysis Should Be Considered in Patients with Cognitive Problems
por: Zetterberg, Henrik, et al.
Publicado: (2010)

Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE ɛ4 negatives
por: Najar, Jenna, et al.
Publicado: (2021)

Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage
por: Tobieson, Lovisa, et al.
Publicado: (2021)

Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression
por: De, Suman, et al.
Publicado: (2019)

Sex differences in CSF biomarkers for neurodegeneration and blood‐brain barrier integrity
por: Skillbäck, Tobias, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
por: Skillbäck, Tobias, et al.
Publicado: (2013)

Peptidome Analysis of Cerebrospinal Fluid by LC-MALDI MS
por: Hölttä, Mikko, et al.
Publicado: (2012)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
por: Hall, Sara, et al.
Publicado: (2016)

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
por: Lautner, Ronald, et al.
Publicado: (2017)

Metabolic Syndrome Is Associated With Poor Cognition: A Population-Based Study of 70-Year-Old Adults Without Dementia
por: Marseglia, Anna, et al.
Publicado: (2021)

Patterns of Alcohol Consumption and Associated Factors in a Population-Based Sample of 70-Year-Olds: Data from the Gothenburg H70 Birth Cohort Study 2014–16
por: Ahlner, Felicia, et al.
Publicado: (2022)

Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer’s Disease: A Pilot Study
por: Thordardottir, Steinunn, et al.
Publicado: (2020)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Molecular forms of neurogranin in cerebrospinal fluid
por: Nazir, Faisal Hayat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sn6fl15u37vvuv8gr1e6qcv0ip